Development of Patient and Caregiver Conceptual Models Investigating the Health-Related Quality of Life Impacts of Malignant Pleural Mesothelioma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hamra G, Loomis D, Dement J. Examining the association of lung cancer and highly correlated fibre size-specific asbestos exposures with a hierarchical Bayesian model. Occup Environ Med. 2014;71:353–7.
Røe OD, Stella GM. Malignant pleural mesothelioma: history, controversy, and future of a man-made epidemic. Eur Respir Rev. 2017;24:115–31.
Van Zandwijk N, Clarke, C., Henderson, D., Musk, W., Fong, K, Penman, A. Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis. 2013;5(6):E254-E307.
Ettinger D. NCCN guidelines insights: malignant pleural mesothelioma, version 3.2016. Off J Natl Comprehen Cancer Netw. 2016;14(7):825-36.
Cavone D, Caputi A, De Maria L, Cannone ESS, Mansi F, Vimercati L. Epidemiology of mesothelioma. Environments 2019;6(7):76.
Bianchi C, Bianchi T. Global mesothelioma epidemic: trend and features. Indian J Occupat Environ Med. 2014;18(2):82-8.
Krówczyńska M, Wilk E. Asbestos Exposure and the Mesothelioma Incidence in Poland. Int J Environ Res Public Health. 2018;15(8):1741.
Musk ABW, de Klerk N, Brims FJ. Mesothelioma in Australia: a review. Med J Aust. 2017;207(10):449–52.
Shah N, Williams, A. Surviving the asbestos epidemic. Insurance Digest (European). 2001:14-8.
Tsao A, Wistuba I, Roth JA, Kindler HL. Malignant pleural mesothelioma. J Clin Oncol. 2009;27(12):2081–90.
Baas P, Scherpereel A, Nowak AK, Fujimoto N, Peters S, Zalcman G. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. The Lancet. 2021;397(10272):375-86.
Nakajima E, Vellanki, J., Larkins, E., Chatterjee, Mishra-Kalyani, PS, Donoghue, M. FDA approval summary: nivolumab in combination with ipilimumab for the treatment of unresectable malignant pleural mesothelioma. Clin Cancer Res. 2022;28(3):446-51.
EMA. Assessment report: ipilimumab/nivolumab (EMA/CHMP/260350/2021). EMA; 2021:1–164.
PBS. Submission: nivolumab plus ipilimumab. Retrieved from: https://wwwpbsgovau/industry/listing/elements/pbac-meetings/psd/2021-03/files/nivolumab-plus-ipilimumab-psd-mar-2021docx. 24th June 2022. 2021:1-42.
Kondola S, Manners D, Nowak AK. Malignant pleural mesothelioma: an update on diagnosis and treatment options. Ther Adv Respir Dis. 2016;10(3):275–88.
Girgis S, Smith AB, Lamber S, Waller A, Girgis A. ‘It sort of hit me like a baseball bat between the eyes’: a qualitative study of the psychosocial experiences of mesothelioma patients and carers. Support Care Cancer. 2019;27(2):631–8.
Sturges J, Hanrahan KJ. Comparing telephone and face-to-face qualitative interviewing: a research note. Qual Res. 2004;4(1):107–18.
NHMRC. National Statement on Ethical Conduct in Human Research 2007 (Updated 2018). www.nhmrc.gov.au/guidelines/publications/e72: National Health and Medical Research Council; 2018.
Clarke V, Braun, V. Thematic analysis. In: Michalos AC (ed) Encyclopaedia of quality of life and well-being research. Springer, Dordrecht. 2014.
Silverman D. Doing qualitative research: a practical handbook. London: SAGE; 2010.
Guest G, Bunce A, Johnson L. An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.
Moore S, Darlison L, Tod AM. Living with mesothelioma: a literture review European. J Cancer Care. 2010;19:458–68.
Brims F, Gunatilake, S., Lawrie, I., Marshall, L., Fogg, C, Chauhan, AJ. Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial. Thorax. 2019;74:354-61.
Arber A, Spener L. ‘It’s all bad news’: the first 3 months following a diagnosis of malignant pleural mesothelioma. Psychooncology. 2013;22(7):1528–33.
Hughes N, Arber A. The lived eperience of patients with pleural mesothelioma. Int J Palliat Nurs. 2009;14(2):66–71.
Ejegi-Memeg S, Sherborne, V., Harrison, M., Taylor, B., Senek, M, Gardiner, C. Patients’ and informal carers’ experience of living with mesothelioma: a systematic rapid review and synthesis of the literature. Eur J Oncol Nurs. 2022;58:102122.
Harrison M, Gardiner C, Taylor B, Ejegi-Memeh S, Darlison L. Understanding the palliative care needs and experiences of people with mesothelioma and their family carers: an integrative systematic review. Palliat Med. 2021;35(6):1039–51.
Warby A, Dhillon HM, Kao S, Vardy JL. A survey of patient and caregiver experience with malignant pleural mesothelioma. Support Care Cancer. 2019;27:4675–86.